Severe obesity, uncontrolled diabetes mellitus, untreated severe OSA, active cancer and psychosis are the accepted contraindications for GH therapy in PWS patients (2,4,7,9). This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.